Position in RLYB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,715,520
+$5,598,266 QoQ
Shares Held
794,720
+0.2% QoQ
Ownership
15.0%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 37 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLYB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. RLYB ranks #153 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in RLYB
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,715,520 | 794,720 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $12,715,520 | 794,720 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $7,117,254 | 793,451 | Shares | Defined | 2026-05-15 | |
| 2026-03-04 | $5,901,687 | 561,798 | Shares | Sole | 2026-03-06 | |
| 2026-03-02 | $4,089,912 | 372,827 | Shares | Sole | 2026-03-06 | |
| 2025-12-31 | $1,162,350 | 1,694,388 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $845,499 | 1,694,388 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $632,153 | 1,870,276 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,169,317 | 1,785,218 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,696,032 | 1,766,701 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,709,110 | 2,315,480 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,068,676 | 2,290,058 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,217,292 | 2,279,618 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,060,014 | 2,535,571 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $10,939,986 | 3,246,287 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $18,370,735 | 3,245,713 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $18,530,405 | 3,245,255 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $21,322,442 | 3,245,425 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $41,873,980 | 2,893,848 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $21,846,354 | 2,893,557 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $20,203,756 | 2,894,521 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,581,789 | 2,891,173 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $50,826,821 | 2,891,173 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||